CDKN1B and breast cancer: Similarly, down-regulation of PES in human breast cancer cells inhibits cell-cycle progression during the G1/S transition, dramatically reducing cyclin D1 and up-regulating the CDK inhibitor p27Kip1 (Li et al., 2009).